After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Medical Devices industry segment. The current market capitalization of Iradimed Corp is $1.18B. A total of 63679.0 shares were traded on the day, compared to an average of 62.54K shares.
In the most recent transaction, Susi Roger E. sold 5,000 shares of IRMD for 90.36 per share on Nov 24 ’25. After the transaction, the CEO, PRESIDENT, CHAIRMAN now owns 2,307,500 company shares. In a previous transaction on Nov 20 ’25, HAWKINS JAMES B sold 3,000 shares at 88.24 per share. IRMD shares that Director owns now total 30,545.
Among the insiders who bought shares, JAMES B HAWKINS acquired of 3,000 shares on Nov 20 ’25 at a per-share price of $88.23. In another insider transaction, Susi Roger E. sold 5,000 shares at $85.59 per share on Nov 18 ’25. Company shares held by the CEO, PRESIDENT, CHAIRMAN now total 2,312,500.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Iradimed Corp pays an annual dividend of $0.68, resulting in a dividend yield of 0.73%, and it has a price to earnings (P/E) ratio of 56.24.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IRMD has a high of $92.50 and a low of $47.48.
As of this writing, IRMD has an earnings estimate of $0.48 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.49 per share and a lower estimate of $0.47. The company reported an EPS of $0.44 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IRMD’s latest balance sheet shows that the firm has $62.50M in Cash & Short Term Investments as of fiscal 2021. There were $2.48M in debt and $6.82M in liabilities at the time. Its Book Value Per Share was $7.73, while its Total Shareholder’s Equity was $72.17M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRMD is Buy with a score of 4.33.
